Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-23T03:52:41.875Z Has data issue: false hasContentIssue false

Recurrent coarctation in Williams syndrome: novel approach of drug-eluting stent implantation

Published online by Cambridge University Press:  16 January 2020

Aphrodite Tzifa*
Affiliation:
Department of Congenital Heart Disease, Mitera Hospital, Hygeia Group, Athens, Greece
Konstantinos S. Mylonas
Affiliation:
Department of Congenital Heart Disease, Mitera Hospital, Hygeia Group, Athens, Greece
Antonios Halapas
Affiliation:
Department of Transcatheter Heart Valves, Hygeia Hospital, Athens, Greece
*
Author for correspondence: Dr A. Tzifa, MD(Res), FRCPCH, Consultant Paediatric Cardiologist, Department of Congenital Heart Disease, Mitera Hospital, Hygeia Group, ErythrouStavrou 6, 15123 Marousi, Athens, Greece. Tel: +306908999961; E-mail: [email protected]

Abstract

Patients with Williams syndrome often present with abnormalities of the vascular wall of the aorta and/or the pulmonary artery. Surgery may result in restenosis of the affected vessel. Herein, we report a case of an infant with multiple recurrences of aortic coarctation successfully treated with Zotarolimus drug-eluting stent.

Type
Brief Report
Copyright
© Cambridge University Press 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mannarino, S, Collins, RT 2nd. Cardiovascular disease in Williams syndrome. Circulation 2013; 127: 21252134.Google Scholar
Collins, RT 2nd, Kaplan, P, Rome, JJ. Stenosis of the thoracic aorta in Williams syndrome. Pediatr Cardiol 2010; 31: 829833.CrossRefGoogle ScholarPubMed
Mannarino, S, Keizman, E, Pasotti, M, Codazzi, AC, De Sando, E, Giamberti, A. A rare case of discrete aortic coarctation in Williams-Beuren syndrome. Diagnostic and therapeutic considerations. Pediatr Med Chir 2015; 37: pmc.2015.120.CrossRefGoogle ScholarPubMed
Cohen, JL, Glickstein, JS, Crystal, MA. Drug-coated balloon angioplasty: a novel treatment for pulmonary artery in-stent stenosis in a patient with Williams Syndrome. Pediatr Cardiol 2017; 38: 17161721.CrossRefGoogle Scholar
Scheinert, D, Duda, S, Zeller, T, et al.The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Cardiovasc Interv 2014; 7: 1019.10.1016/j.jcin.2013.05.022CrossRefGoogle ScholarPubMed
Palmerini, T, Benedetto, U, Biondi-Zoccai, G, et al.Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2015; 65: 24962507.CrossRefGoogle ScholarPubMed
Lee, KJ, Seto, W, Benson, L, Chaturvedi, RR. Pharmacokinetics of sirolimus-eluting stents implanted in the neonatal arterial duct. Circ Cardiovasc Interv 2015; 8: e002233.doi: 10.1161/CIRCINTERVENTIONS.114.002233CrossRefGoogle ScholarPubMed
Wessely, R, Schomig, A, Kastrati, A. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol 2006; 47: 708714.CrossRefGoogle Scholar
Burke, SE, Kuntz, RE, Schwartz, LB. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006; 58: 437446.CrossRefGoogle ScholarPubMed
Khan, A, Qureshi, A, Justino, H. Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood. Catheter Cardiovasc Interv 2019; 94: 233242.CrossRefGoogle ScholarPubMed
Supplementary material: File

Tzifa et al. supplementary material

Tzifa et al. supplementary material

Download Tzifa et al. supplementary material(File)
File 625.2 KB